Let's consider two such companies: Jazz Pharmaceuticals (NASDAQ: JAZZ) and Netflix (NASDAQ: NFLX). It's never good to be too reliant on a single product, and until recently Jazz Pharmaceuticals -- based in Dublin, Ireland -- relied heavily on Xyrem, a medicine that helps treat narcolepsy. The deal closed in May and cost Jazz $7.2 billion in cash and stock. Read More...
Let’s consider two such companies: Jazz Pharmaceuticals (NASDAQ: JAZZ) and Netflix (NASDAQ: NFLX). It’s never good to be too reliant on a single product, and until recently Jazz Pharmaceuticals — based in Dublin, Ireland — relied heavily on Xyrem, a medicine that helps treat narcolepsy. The deal closed in May and cost Jazz $7.2 billion in cash and stock.
Add Comment